Swiss stocks - Factors to watch on June 21

HBM Healthcare Investments AG

21/06/2021 05:56

ZURICH/BERLIN, June 21 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
    
    CORONAVIRUS
    Switzerland plans to allow 12- to 15-year olds to receive
vaccinations against COVID-19 as soon as next week, government
vaccine chief Christoph Berger told Swiss newspaper NZZ in an
interview published on Sunday.
    
    COMPANY STATEMENTS
    * Novartis  NOVN.S  said new data for Zolgensma, its
one-time treatment for spinal muscular atrophy, found children
given the gene therapy before they developed symptoms had
age-appropriate development.  NOVN.S  
    * HBM   HBMN.S  said its portfolio company Ambrx Biopharma 
raised $126 million in an initial public offering.  HBMN.S 
    * Peach Property 
Recent news on HBM Healthcare Investments AG
See all news
Swiss stocks - Factors to watch on October 23
Today 05:47
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
24/07/2026 05:41
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
13/05/2026 05:42
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
14/12/2025 18:39
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics
08/12/2025 13:58